Increased prevalence of some birth defects in Korea, 2009-2010

Dirga Kumar Lamichhane1, Jong-Han Leem2,3, Myungsook Park1

  • 1Department of Social and Preventive Medicine, School of Medicine, Inha University, Incheon, Korea.

Insights

Birth defect prevalence in Korea was 548.3 per 10,000 infants, with circulatory and genitourinary systems most affected. Metropolitan areas showed higher rates, suggesting environmental factors may play a role.

Area of Science:

  • Public Health
  • Pediatrics
  • Epidemiology

Background:

  • Birth defects are a significant cause of infant mortality.
  • Increasing trends in birth defect prevalence are noted, particularly in industrialized regions.
  • This study focuses on estimating birth defect rates in Korea.

Purpose of the Study:

  • To estimate the prevalence and identify types of birth defects in Korean infants.
  • To analyze spatio-temporal variations in birth defect rates.
  • To investigate potential contributing factors, including environmental influences.

Main Methods:

  • Utilized medical insurance benefit data from 403,250 infants (<1 year old).
  • Data sourced from the National Health Insurance Corporation covering seven metropolitan areas in Korea.
  • Study period: 2009-2010.

Main Results:

  • Overall birth defect prevalence: 548.3 per 10,000 births (95% CI: 541.1-555.6).
  • Most common defects: circulatory system (180.8/10,000), genitourinary tract (130.1/10,000), and musculoskeletal system (105.7/10,000).
  • Higher prevalence rates observed in metropolitan areas compared to national averages.

Conclusions:

  • Metropolitan areas exhibit relatively higher rates for certain birth defects.
  • Improved clinical management and prenatal diagnosis likely contribute to observed rates of septal heart defects and undescended testis.
  • Environmental exposure is a potential critical factor; a national birth defect registry and environmental surveillance are recommended.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
10
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
73.7K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.9K
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
5.7K